[HTML][HTML] Prehabilitation, enhanced recovery after surgery, or both? A narrative review

C Gillis, O Ljungqvist, F Carli - British journal of anaesthesia, 2022 - Elsevier
This narrative review presents a biological rationale and evidence to describe how the
preoperative condition of the patient contributes to postoperative morbidity. Any preoperative …

Vitamin D and sarcopenia: potential of vitamin D supplementation in sarcopenia prevention and treatment

R Uchitomi, M Oyabu, Y Kamei - Nutrients, 2020 - mdpi.com
Skeletal muscle, the largest organ in the human body, accounting for approximately 40% of
body weight, plays important roles in exercise and energy expenditure. In the elderly, there …

Advances in understanding of the role of lipid metabolism in aging

KW Chung - Cells, 2021 - mdpi.com
During aging, body adiposity increases with changes in the metabolism of lipids and their
metabolite levels. Considering lipid metabolism, excess adiposity with increased lipotoxicity …

Farnesol prevents aging-related muscle weakness in mice through enhanced farnesylation of Parkin-interacting substrate

JH Bae, A Jo, SC Cho, YI Lee, TI Kam, CL You… - Science translational …, 2023 - science.org
Peroxisome proliferator–activated receptor-γ coactivator-1α (PGC-1α) is a master regulator
of mitochondrial biogenesis. Reduced PGC-1α abundance is linked to skeletal muscle …

Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis

G Livshits, A Kalinkovich - Ageing research reviews, 2019 - Elsevier
Sarcopenia, obesity and their coexistence, obese sarcopenia (OBSP) as well as
atherosclerosis-related cardio-vascular diseases (ACVDs), including chronic heart failure …

The effects of lifestyle and diet on gut microbiota composition, inflammation and muscle performance in our aging society

B Strasser, M Wolters, C Weyh, K Krüger, A Ticinesi - Nutrients, 2021 - mdpi.com
Living longer is associated with an increased risk of chronic diseases, including impairments
of the musculoskeletal and immune system as well as metabolic disorders and certain …

The KEAP1-NRF2 system in healthy aging and longevity

D Matsumaru, H Motohashi - Antioxidants, 2021 - mdpi.com
Aging is inevitable, but the inherently and genetically programmed aging process is
markedly influenced by environmental factors. All organisms are constantly exposed to …

Experimental models of sarcopenia: bridging molecular mechanism and therapeutic strategy

S Mankhong, S Kim, S Moon, HB Kwak, DH Park… - Cells, 2020 - mdpi.com
Sarcopenia has been defined as a progressive decline of skeletal muscle mass, strength,
and functions in elderly people. It is accompanied by physical frailty, functional disability …

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy

Y Zheng, S Wang, J Wu, Y Wang - Journal of Translational Medicine, 2023 - Springer
Metabolic dysfunction-associated fatty liver disease (MAFLD) is among the most widespread
metabolic disease globally, and its associated complications including insulin resistance …

Improving rehabilitation in sarcopenia: a randomized‐controlled trial utilizing a muscle‐targeted food for special medical purposes

M Rondanelli, E Cereda, C Klersy… - Journal of cachexia …, 2020 - Wiley Online Library
Background Sarcopenia is a disease associated with aging and a negative prognosis.
Consensus‐based treatment consists in targeting muscle mass and function through …